Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
lipoaspirate micronized + leukocyte-poor platelet-rich plasma
- Development stage
- Preclinical
- Modality
- Native Immune Cells → Adoptive Cell Transfer → Cell Therapies, Adipose-derived MSCs → Mesenchymal Stem Cells → Adult Stem Cells → Stem Cell Therapies → Cell Therapies, Other Cell Types → Cell Therapies
- Administration
- Intraarticular, Intralesional, Soft Tissue Injection, Intradermal, Subcutaneous, Topical
01
Overview
Lipoaspirate micronized + leukocyte-poor platelet-rich plasma is a combination regenerative therapy that merges two autologous biologic products. The first component, micronized lipoaspirate, is derived from mechanically processed adipose (fat) tissue to concentrate stromal vascular fraction (SVF) cells, including adipose-derived stem cells and extracellular matrix components. This process removes most mature adipocytes and oil, resulting in an injectable product rich in regenerative cells[2]. The second component, leukocyte-poor platelet-rich plasma (PRP), is prepared by centrifuging the patient's blood to yield a high concentration of platelets with reduced white blood cell content[7]. PRP contains growth factors and cytokines that promote tissue repair and modulate inflammation[1][5][7]. When combined, these therapies are intended to synergistically enhance healing by providing both cellular elements for regeneration (from SVF) and bioactive factors for tissue repair (from PRP). This combination has been explored primarily in musculoskeletal medicine for conditions such as osteoarthritis, tendon injuries, chronic wounds, scars, or other soft-tissue disorders.
- Other names
- lipoaspirate micronized and leukocyte-poor platelet-rich plasma
Beyond the preview
Go deeper on lipoaspirate micronized + leukocyte-poor platelet-rich plasma.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on lipoaspirate micronized + leukocyte-poor platelet-rich plasma.